Showing results (621-630 of 834) with videos related to
Sort By:
Pageof 84
Frontiers in Endocrinology|December 19, 2022
Multiomics signatures of type 1 diabetes with and without albuminuriaMarc Clos-Garcia, Tarunveer S Ahluwalia, Signe A Winther, et al.Diabetologia|October 16, 2020
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trialKristine Færch, Martin B Blond, Lea Bruhn, et al.BMJ Open|November 30, 2019
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.Journal of Diabetes and Its Complications|November 25, 2025
Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney functionShigehiro Katayama, Stefan D Anker, Dalong Zhu, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.Nephron|January 11, 2023
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney DiseaseTherese Adrian, Mads Hornum, Filip Krag Knop, et al.Journal of the American College of Cardiology|May 20, 2021
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, George L Bakris, Bertram Pitt, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 24, 2024
New Diabetic Treatment by Alleviation of Autonomic Nervous System Dysfunction Measured as Periosteal Pressure Sensitivity at Sternum Improves Empowerment, Treatment Satisfaction, and Self-Reported Health of People with Type 2 Diabetes: A Randomized TrialSofie Korsgaard Hecquet, Søren Ballegaard, Ebbe Eldrup, et al.Cardiovascular Diabetology|July 19, 2022
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetesLuis F Ferreira-Divino, Tommi Suvitaival, Viktor Rotbain Curovic, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 20, 2026
Extracellular matrix proteins as risk markers for complications in type 1 diabetesMarte Opseth Rygg, Alexandra Louise Møller, Viktor Rotbain Curovic, et al.Pageof 84